Mia's Feed
Medical News & Research

Significant Rise in Nicotine Pouch Ingestions by Young Children Highlights Growing Safety Concerns

Significant Rise in Nicotine Pouch Ingestions by Young Children Highlights Growing Safety Concerns

Share this article

A recent study reports a dramatic 763% increase in nicotine pouch ingestions among young children, highlighting urgent safety concerns and the need for preventive measures.

2 min read

A recent study has documented a startling rise in the number of young children ingesting nicotine pouches, a relatively new form of nicotine product. Conducted by researchers from the Center for Injury Research and Policy at Nationwide Children's Hospital and the Central Ohio Poison Center, the investigation analyzed calls made to U.S. poison centers from 2020 to 2023. The findings reveal an alarming 763% increase in reported cases of children under the age of 6 swallowing nicotine pouches during this period.

Nicotine pouches, which consist of nicotine powder designed to be placed in the mouth, were not tracked in national poison data until 2020. Since then, the ingestion rates among young children have surged, even as cases involving other nicotine formulations like gum, lozenges, e-liquids, and powders have declined. The data show these pouch ingestions are more likely to lead to serious medical outcomes or require hospital admissions compared to other nicotine products.

The study assessed nearly 135,000 cases of nicotine exposure in children under 6 reported to poison centers over 13 years. Most incidents occurred at home, predominantly involving children under 2 years old. While the majority experienced minor or no effects, there were 39 cases with severe outcomes and two fatalities. Overall, nicotine ingestion rates increased by 59% between 2010 and 2015, driven largely by liquid nicotine, which saw a 450% rise before decreasing by 45% after legislation mandated child-resistant packaging.

Dr. Hannah Hays, a co-author of the study and medical director at the Central Ohio Poison Center, emphasizes the importance of increased vigilance: "Nicotine pouches are a serious and growing hazard among young children. The rapid rise and severity of these ingestions underscore the need for ongoing surveillance and preventive measures."

The research also highlights the role of legislation—such as the Child Nicotine Poisoning Prevention Act of 2015—in reducing liquid nicotine ingestions. However, nicotine products, especially flavored and attractively packaged ones, still pose significant risks. To protect children, experts recommend storing nicotine products out of reach and sight in locked cabinets, avoiding using them in front of children, and keeping emergency contact information, like the Poison Help Line, readily accessible.

This study underscores the urgent need for enhanced safety measures and continuous monitoring to prevent young children from accidental nicotine ingestion, with special attention to newer forms like nicotine pouches.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

China Commits $500 Million to WHO Amid US Support Withdrawal

China commits $500 million to WHO over five years, stepping up to lead in global health support following the US's withdrawal from the organization, emphasizing international solidarity and health security.

AI Set to Influence Medicare Treatment Approvals in Future Policy Trials

The U.S. government is launching a pilot program to test AI algorithms in Medicare treatment approvals, aiming to reduce waste and improve decision-making, but safety and ethics concerns remain.

Hourly Rhythms in Brain Cells Regulate Stress Activation and Deactivation

New research uncovers how brain cells controlling stress activate in hourly cycles, influencing alertness and hormone levels, with implications for mental health and sleep regulation.

New Study Identifies Protein ADAR1 as a Promising Target for Glioblastoma Treatment

Researchers have identified the protein ADAR1 as a promising target to slow glioblastoma growth and activate the immune system, paving the way for new therapies for this deadly brain cancer.